Recurrent Drug-Eluting Stent In-Stent Restenosis: A State-of-the-Art Review of Pathophysiology, Diagnosis, and Management
- 1 September 2020
- journal article
- review article
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 21 (9) , 1157-1163
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Repeat Revascularization After Contemporary Percutaneous Coronary InterventionCirculation: Cardiovascular Interventions, 2012
- Mechanisms of In-Stent Restenosis After Drug-Eluting Stent ImplantationCirculation: Cardiovascular Interventions, 2011
- In-Stent Restenosis in the Drug-Eluting Stent EraJACC, 2010
- Diagnostic Accuracy of 320-Row Multidetector Computed Tomography Coronary Angiography to Noninvasively Assess In-Stent RestenosisInvestigative Radiology, 2010
- Diagnostic accuracy of 64-slice computed tomography coronary angiography for the detection of in-stent restenosis: A meta-analysisJournal of Nuclear Cardiology, 2010
- New Stent Implantation for Recurrences After Stenting for In-Stent RestenosisJACC, 2009
- Tratamiento de la reestenosis de un stent liberador de fármacos con otro stent liberador de fármacos: ¡no fallar en el segundo intento!Revista Espanola de Cardiologia, 2008
- In Vivo Comparison Between Optical Coherence Tomography and Intravascular Ultrasound for Detecting Small Degrees of In-Stent Neointima After Stent ImplantationJACC: Cardiovascular Interventions, 2008
- Meta-Analysis of Angiographic Versus Intravascular Ultrasound Parameters of Drug-Eluting Stent Efficacy (from TAXUS IV, V, and VI)The American Journal of Cardiology, 2007
- Intravascular Brachytherapy Versus Drug-Eluting Stents for the Treatment of Patients With Drug-Eluting Stent RestenosisThe American Journal of Cardiology, 2006